isoproterenol has been researched along with Ovarian Neoplasms in 6 studies
Isoproterenol: Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant.
isoprenaline : A secondary amino compound that is noradrenaline in which one of the hydrogens attached to the nitrogen is replaced by an isopropyl group. A sympathomimetic acting almost exclusively on beta-adrenergic receptors, it is used (mainly as the hydrochloride salt) as a bronghodilator and heart stimulant for the management of a variety of cardiac disorders.
Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Isoproterenol treatment resulted in a significant increase in tumor volume and infiltration in the SKOV3ip1 in vivo model, which was blocked by propranolol." | 1.33 | Stress hormone-mediated invasion of ovarian cancer cells. ( Bhatty, R; Cole, SW; Gershenson, DM; Han, L; Kamat, AA; Landen, CN; Li, Y; Lutgendorf, S; Sood, AK; Thaker, PH, 2006) |
| " isoprenaline was selectively depressed by doxorubicin (no changes in chronotropic responses) and this adverse effect of doxorubicin was also prevented in zofenopril+doxorubicin pretreated rats." | 1.31 | Cardioprotective effects of zofenopril, a new angiotensin-converting enzyme inhibitor, on doxorubicin-induced cardiotoxicity in the rat. ( Bigioni, M; Evangelista, S; Goso, C; Maggi, CA; Manzini, S; Sacco, G, 2001) |
| " In this study, both LMF and Zn-alpha2-glycoprotein have been shown to stimulate glycerol release from isolated murine epididymal adipocytes with a comparable dose-response profile." | 1.30 | Biological evaluation of a lipid-mobilizing factor isolated from the urine of cancer patients. ( Barber, MD; Hirai, K; Hussey, HJ; Price, SA; Tisdale, MJ, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rangarajan, S | 1 |
| Enserink, JM | 1 |
| Kuiperij, HB | 1 |
| de Rooij, J | 1 |
| Price, LS | 1 |
| Schwede, F | 1 |
| Bos, JL | 1 |
| Lutgendorf, SK | 2 |
| Cole, S | 1 |
| Costanzo, E | 1 |
| Bradley, S | 1 |
| Coffin, J | 1 |
| Jabbari, S | 1 |
| Rainwater, K | 1 |
| Ritchie, JM | 1 |
| Yang, M | 1 |
| Sood, AK | 3 |
| Bhatty, R | 1 |
| Kamat, AA | 2 |
| Landen, CN | 2 |
| Han, L | 1 |
| Thaker, PH | 2 |
| Li, Y | 2 |
| Gershenson, DM | 2 |
| Lutgendorf, S | 1 |
| Cole, SW | 2 |
| Han, LY | 1 |
| Arevalo, JM | 1 |
| Takahashi, R | 1 |
| Lu, C | 1 |
| Jennings, NB | 1 |
| Armaiz-Pena, G | 1 |
| Bankson, JA | 1 |
| Ravoori, M | 1 |
| Merritt, WM | 1 |
| Lin, YG | 1 |
| Mangala, LS | 1 |
| Kim, TJ | 1 |
| Coleman, RL | 1 |
| Felix, E | 1 |
| Sanguino, AM | 1 |
| Newman, RA | 1 |
| Lloyd, M | 1 |
| Kundra, V | 1 |
| Lopez-Berestein, G | 1 |
| Hirai, K | 1 |
| Hussey, HJ | 1 |
| Barber, MD | 1 |
| Price, SA | 1 |
| Tisdale, MJ | 1 |
| Sacco, G | 1 |
| Bigioni, M | 1 |
| Evangelista, S | 1 |
| Goso, C | 1 |
| Manzini, S | 1 |
| Maggi, CA | 1 |
6 other studies available for isoproterenol and Ovarian Neoplasms
| Article | Year |
|---|---|
Cyclic AMP induces integrin-mediated cell adhesion through Epac and Rap1 upon stimulation of the beta 2-adrenergic receptor.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adrenergic beta-Agonists; Carcinoma; Cell Adhesion; Cyclic A | 2003 |
Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Anti-Inflammatory Agents; Epinephrine; Female; | 2003 |
Stress hormone-mediated invasion of ovarian cancer cells.
Topics: Animals; Enzyme-Linked Immunosorbent Assay; Epinephrine; Female; Humans; Hydrocortisone; Isoproteren | 2006 |
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma.
Topics: Animals; Carcinoma; Cell Line, Tumor; Disease Models, Animal; Drug Combinations; Enzyme Inhibitors; | 2006 |
Biological evaluation of a lipid-mobilizing factor isolated from the urine of cancer patients.
Topics: Adenylyl Cyclases; Adipocytes; Adrenergic beta-Agonists; Animals; Body Composition; Cachexia; Cells, | 1998 |
Cardioprotective effects of zofenopril, a new angiotensin-converting enzyme inhibitor, on doxorubicin-induced cardiotoxicity in the rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antineoplastic Agents; Body Weight; Captopril; Ca | 2001 |